CFO of ImmunoGen Inc. (IMGN, Financial) Gregory D Perry sells 8,333 shares of IMGN on 07/15/2011 at an average price of $15.12 a share.
Immunogen Inc. has a market cap of $1.16 billion; its shares were traded at around $15.4 with and P/S ratio of 82.97. Immunogen Inc. had an annual average earning growth of 6.9% over the past 10 years.
For the complete insider trading history of IMGN, click here.
Immunogen Inc. has a market cap of $1.16 billion; its shares were traded at around $15.4 with and P/S ratio of 82.97. Immunogen Inc. had an annual average earning growth of 6.9% over the past 10 years.
CFO Recent Trades:
- CFO Gregory D Perry sold 8,333 shares of IMGN stock on 06/29/2011 at the average price of 12.07. The price of the stock has increased by 27.59% since.
Directors and Officers Recent Trades:
- Director Mitchel Sayare sold 10,000 shares of IMGN stock on 06/24/2011 at the average price of 11.7. Mitchel Sayare owns at least 403,136 shares after this. The price of the stock has increased by 31.62% since.
- Director Mitchel Sayare sold 10,000 shares of IMGN stock on 06/10/2011 at the average price of 11.69. Mitchel Sayare owns at least 413,136 shares after this. The price of the stock has increased by 31.74% since.
- Director Mitchel Sayare sold 10,000 shares of IMGN stock on 05/27/2011 at the average price of 12.24. Mitchel Sayare owns at least 423,136 shares after this. The price of the stock has increased by 25.82% since.
- Director Mitchel Sayare sold 10,000 shares of IMGN stock on 05/13/2011 at the average price of 13.23. Mitchel Sayare owns at least 433,136 shares after this. The price of the stock has increased by 16.4% since.
- Director Mitchel Sayare sold 20,000 shares of IMGN stock on 04/29/2011 at the average price of 13.28. Mitchel Sayare owns at least 443,136 shares after this. The price of the stock has increased by 15.96% since.
For the complete insider trading history of IMGN, click here.
